ArticleOncotarget2018

Targeting pediatric sarcoma with a bispecific ligand immunotoxin targeting urokinase and epidermal growth factor receptors.

Kristy Pilbeam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.